SEXUALLY TRANSMITTED INFECTION RESEARCH FOUNDATION (STIRF)

Registered charity 1075316 · accounts filings on the Charity Commission register · also known as STIRF

Funding research in HIV: currently funding research in metabolic diseases and causes of blood eosinophiliaFunding for Sexually Transmitted Diseases: invitation sent to local centresFunding for HIV course in Russian federation to health care workers: due for 2009

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£51k
Latest spending
£960
Registered
1999
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that total income for the financial year was £50,000, with trustees spending £960 on projects and related costs. The filing notes that Jo-Li Trust has agreed to part-fund the charity with £50,000 annually until 2029. The accounts were independently examined by Ormerod Rutter Ltd.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: Jo-Li Trust (100% of income)
Jo-Li Trust has agreed to part-fund STIRF by donating £50,000 annually until 2029 — page 2
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Birmingham City · Coventry City · Dudley · Sandwell · Solihull · Walsall · Wolverhampton

Income and spending

Financial year endIncomeSpending
05/04/2025£51k£960
05/04/2024£123k£97k
05/04/2023£259£23k
05/04/2022£46k£31k
05/04/2021£44k£34k

Common questions

Is SEXUALLY TRANSMITTED INFECTION RESEARCH FOUNDATION (STIRF) financially healthy?

Per its FY2025 accounts: The accounts state that total income for the financial year was £50,000, with trustees spending £960 on projects and related costs. The filing notes that Jo-Li Trust has agreed to part-fund the charity with £50,000 annually until 2029. The accounts were independently examined by Ormerod Rutter Ltd. Its FY2025 accounts were independently examined.